You are here

Press Releases

AdvaMed Applauds Congressional Passage of CARES Act
Press Release | March 27, 2020
WASHINGTON, D.C. – Today, AdvaMed President and CEO Scott Whitaker released a statement applauding congressional passage of the Coronavirus Aid, Relief, and Economic Security (CARES) Act. “These are extraordinary times, and we appreciate Congress... Read More
Industry Welcomes Government Direction On Allocation of Ventilators
Press Release | March 24, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today sent a letterto the Federal Emergency Management Agency (FEMA) and the administration calling for centralization of procurement and allocation decision-making for medical... Read More
Diagnostics Manufacturers Ramping Up COVID-19 Tests to Combat Pandemic
Press Release | March 20, 2020
WASHINGTON, D.C. – Several diagnostics companies have received or will soon receive FDA Emergency Use Authorizations (EUA) that will provide crucial capacity for the U.S. to significantly ramp up testing for the coronavirus (COVID-19).  “The medical... Read More
FDA Commissioner Hahn Addresses AdvaMed Board of Directors on Coronavirus
Press Release | March 17, 2020
WASHINGTON, D.C. – FDA Commissioner Dr. Stephen Hahn joined a special meeting of AdvaMed’s Board of Directors today to discuss how the medical technology industry and FDA can continue their work together to ensure patients and health care providers... Read More
VALID Act Introduction Advances Diagnostics Regulatory Reform
Press Release | March 5, 2020
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker and AdvaMedDx Executive Director Susan Van Meter issued the following statements upon introduction today in the House and Senate of the Verifying Accurate, Leading-edge IVCT Development (... Read More
MedTech Fighting Coronavirus on Multiple Fronts
Press Release | February 26, 2020
WASHINGTON, D.C. – Since the onset of the coronavirus (COVID-19) outbreak, at least 31 AdvaMed member companies have donated medical products worth approximately $26.8 million and made cash donations worth $4.1 million to the China Red Cross... Read More
EPA Ethylene Oxide Value at Odds with Public Health, Best Science
Press Release | February 19, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) again urged the U.S. EPA to abandon its ethylene oxide (EtO) risk assessment value for one that is more feasible, based on the best available science and that will not... Read More
Medical Device Manufacturers Raise Public Health Concerns Over EPA Ethylene Oxide Value
Press Release | February 12, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) this week urged the U.S. EPA to reassess its risk assessment value for ethylene oxide (EtO), arguing the threshold is neither practical nor is it based on the latest science,... Read More
AdvaMed Drives MedTech Industry Inclusion and Diversity Efforts: “MedTech Leaders Must be as Diverse as the Patients They Serve”
Press Release | February 11, 2020
WASHINGTON, D.C. – This week, AdvaMed President and CEO, Scott Whitaker, and AdvaMed CFO and Executive Director of AdvaMed Advance, Jennifer Brearey, co-authored an editorial outlining steps the medical technology industry is taking to cultivate... Read More
AdvaMed and Biocom to Strategically Partner for The Digital MedTech Conference 2020
Press Release | February 10, 2020
WASHINGTON and SAN DIEGO – February 10, 2020 – The Advanced Medical Technology Association (AdvaMed) and Biocom, the association representing the California life science industry, today announced a joint partnership to collaboratively produce The... Read More

Pages